Veradermics Inc (MANE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MANE Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Veradermics Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Dec 31 2024)
Assets
Cash & cash equivalent819.90
Available-for-sale Securities, Debt Securities, Current MA815.46
Cash & Short-term Investments1,634.00
Notes Receivable, Current1.59
Prepaid Expense And Other Assets Current6.54
Total Current Assets824.75
Equipment/Property/Plant Net0.04
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.95
Operating Lease Right Of Use Asset0.27
Total Assets825.74
Liabilities
Accounts Payable, Current AC5.92
Accrued Liabilities, Current AC5.40
Other Liabilities, Current0.38
Total Current Liabilities11.69
Total Long-term Debt0.00
Other liabilities, Noncurrent0.43
OperatingLeaseLiabilityNoncurrent-
Total Liabilities12.12
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock989.26
Retained Earnings / Accumulated Deficit-174.16
Accumulated Other Comprehensive Income-0.90
Other Equity-0.90
Common Stockholder's Equity813.61
Non-controlling interests & other0.00
Total Stockholder's Equity813.61
Liabilities & Stockholder's Equity825.74
4 historic quarters locked

Sign in to unlock the full Veradermics Inc balance sheet history.

About Veradermics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001827635-26-000030

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.